Literature DB >> 9293827

Effect of renal insufficiency on outcome following infrarenal aortic surgery.

R J Powell1, S P Roddy, G H Meier, R J Gusberg, M S Conte, B E Sumpio.   

Abstract

BACKGROUND: This study reviewed the effect of preoperative renal insufficiency on outcome following elective infrarenal aortic surgery.
METHODS: The charts of 210 consecutive patients undergoing aortic surgery (occlusive disease, 15%; aneurysmal disease, 78%; or combined disease, 7%) from 1990 to 1995 were categorized into three groups based on preoperative creatinine ([Cr] group 1 Cr < 1.5, n = 171; group 2 Cr 1.5 to 1.7, n = 22; and group 3 Cr > or = 1.8, n = 17) and calculated creatinine clearance ([CrCl] CrCl > 45 mL/min, n = 162 versus CrCl < 45 mL/min, n = 48). Patients with renal artery stenosis or those who required suprarenal cross clamping or emergency procedures were excluded. Differences in postoperative intensive care unit (ICU) stay, ventilator days, dialysis dependence, morbidity, and, mortality were compared.
RESULTS: Patients in groups 2 and 3 had an increased incidence of postoperative dialysis dependence (group 2 9%, group 3 8%) when compared with patients in group 1 (group 1: 0%, P < 0.05). Patients in the CrCl > 45 group had a lower mortality rate when compared with patients with a CrCl < 45 (CrCl > 45 0.6% versus CrCl < 45 8%, P <0.05) a lower incidence of dialysis (0% versus 7%, P <0.05), and a lower incidence of postoperative serum creatinine elevation from baseline (CrCl > 45 8% versus CrCl < 45 18%, P <0.05). There was no significant difference in morbidity, ICU stay, or ventilator days between the groups. Upon regression analysis, preoperative CrCl but not Cr was predictive of postoperative mortality (P <0.05). Serum Cr was more predictive than CrCl of impaired renal function postoperatively.
CONCLUSIONS: Preoperative CrCl is more accurate than Cr as a predictor of postoperative mortality. Patients with preoperative CrCl < 45 mL/minute who undergo elective aortic surgery have a significant increase in postoperative cardiac-related mortality and dialysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9293827     DOI: 10.1016/s0002-9610(97)00069-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  Repair of a pararenal abdominal aortic aneurysm with bilateral renal artery stenosis using a rapid infusion pump for renal perfusion: report of a case.

Authors:  Atsushi Aoki; Kenji Sangawa
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

2.  Incidence, risk factors and prognosis of changes in serum creatinine early after aortic abdominal surgery.

Authors:  Christoph Ellenberger; Alexandre Schweizer; John Diaper; Afksendiyos Kalangos; Nicolas Murith; Gregory Katchatourian; Aristote Panos; Marc Licker
Journal:  Intensive Care Med       Date:  2006-08-08       Impact factor: 17.440

Review 3.  Endovascular Treatment versus Open Repair for Abdominal Aortic Aneurysms: The Influence of Fitness in Decision Making.

Authors:  Konstnatinos G Moulakakis; Ilias Dalainas; John Kakisis; Spyridon Mylonas; Christos D Liapis
Journal:  Int J Angiol       Date:  2013-03

4.  Incidence and circumstances of serum creatinine increase after abdominal aortic surgery.

Authors:  Frédérique Ryckwaert; Pierre Alric; Marie-Christine Picot; Kela Djoufelkit; Pascal Colson
Journal:  Intensive Care Med       Date:  2003-08-27       Impact factor: 17.440

5.  A perioperative strategy for abdominal aortic aneurysm in patients with chronic renal insufficiency.

Authors:  Makoto Haga; Katsuyuki Hoshina; Kunihiro Shigematsu; Toshiaki Watanabe
Journal:  Surg Today       Date:  2015-12-08       Impact factor: 2.549

6.  Effects of alprostadil and iloprost on renal, lung, and skeletal muscle injury following hindlimb ischemia-reperfusion injury in rats.

Authors:  Dilek Erer; Abdullah Özer; Hüseyin Demirtaş; İpek Işık Gönül; Halil Kara; Hande Arpacı; Faruk Metin Çomu; Gürsel Levent Oktar; Mustafa Arslan; Ayşegül Küçük
Journal:  Drug Des Devel Ther       Date:  2016-08-19       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.